This article is more than 5 years old. Information may no longer be current.

Health Canada approves Trab360 for open-angle glaucoma

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Health Canada has approved the Trab360 trabeculotomy system, according to a Sight Sciences press release.

The fully integrated, single-handed, single-use device allows for 360° angle access to Schlemm’s canal with a single, sub-2-mm clear corneal incision, the release said.

Health Canada has approved its use for the microcatheterization of Schlemm’s canal and for cutting the trabecular meshwork to lower IOP in patients with open-angle glaucoma.

“Given its unique ability to access all 360° of diseased meshwork from an ab interno approach, the Trab360 is an attractive, less invasive option for my glaucoma patients with moderate to advanced disease,” Paul Harasymowycz, MD, head of glaucoma at the University of Montreal and medical director of the Montreal Glaucoma Institute and the Quebec Glaucoma Foundation, said in the release.